INGN Inogen, Inc.

NASDAQ
$5.36

Inogen, Inc. (INGN) is expected to report earnings on November 5, 2026, after the market close. The stock has had a Post-Earnings Announcement Drift (PEAD) of -9.1% since its last earnings release on August 6, 2026.

Inogen Beat Consensus Estimates, Lowers Guidance
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $5.44

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Inogen, Inc.

Inogen Inc is a medical technology company that develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.